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SIFAT-SIFAT SITOTOKSIK, MUTAGENIK DAN PATOGEN ORAL YANG 
BERKAITAN SIFAT-SIFAT ANTIMIKROB CLINACANTHUS NUTANS 
 
ABSTRAK 
 
Clinacanthus nutans (C. nutans) atau nama tempatan dikenali sebagai rumput 
Belalai gajah adalah pokok herba saka yang telah digunakan secara tradisional untuk 
rawatan pelbagai penyakit di Malaysia. Objektif kajian ini adalah untuk menentukan 
sebatian fitokimia dalam ekstrak etanol dan ekstrak akueus daun C. nutans 
menggunakan Kromatografi Gas Spektrometer Jisim (GCMS) dan menilai kesan 
sitotoksik menggunakan ujian MTT pada sel-sel fibroblas gingiva manusia dan untuk 
menilai kesan mutagen menggunakan ujian Ames serta menentukan sifat-sifat 
antimikrob dengan menggunakan ujian resapan agar dan ujian kepekatan perencat 
minima (MIC). Jumlah keseluruhan, 53 sebatian fitokimia telah dikenal pasti dari 
ekstrak daun C. nutans. Sebatian ini diklasifikasikan kepada beberapa kelas sebatian 
seperti fenol, flavonoid, terpenoid, asid lemak, alkana dan hidrokarbon, ester, keton, 
furan, sulfur dan sebatian nitrogen. Kajian sitotoksik in vitro ekstrak etanol dan ekstrak 
akueus daun C. nutans dalam pelbagai kepekatan (6,400; 3,200; 1,600; 800; 400; 200; 
100; 50 dan 25 μg / ml) pada sel-sel fibroblas gingiva manusia (HGF-1) menggunakan 
ujian MTT tidak menunjukkan sebarang kesan sitotoksik. Ujian Ames terhadap empat 
jenis S. Typhimurium, TA98, TA100, TA1535 dan TA1537 dirawat dengan ekstrak 
etanol dan ekstrak akueus daun C. nutans tidak menunjukkan sebarang kesan mutagen 
dalam kehadiran dan tanpa kehadiran campuran sistem pengaktifan metabolik (S9) 
berasaskan pada bilangan koloni. Kajian antimikrob dengan menggunakan ujian 
resapan agar menunjukkan bahawa pertumbuhan Staphylococcus aureus (S. aureus) 
xx 
 
dan Actinomyces viscosus (A. viscosus) direncatkan oleh ekstrak etanol dan ekstrak 
akueus daun C. nutans. Walau bagaimanapun, ekstrak-ekstrak ini tidak menunjukkan 
sebarang aktiviti antimikrob terhadap Enterococcus faecalis (E. faecalis), 
Porhyromonas gingivalis (P. gingivalis) dan Candida albicans (C. albicans). Ekstrak 
etanol daun C. nutans menunjukkan aktiviti antimikrob yang lebih baik berbanding 
ekstrak akueus daun C. nutans terhadap A. viscosus. Ekstrak etanol daun C. nutans 
menunjukkan nilai MIC sebanyak 102,400 μg/ml terhadap A. viscosus dan 204,800 
μg/ml terhadap S. aureus. Ekstrak akueus daun C. nutans menunjukkan nilai MIC 
sebanyak 204,800 μg/ml terhadap A. viscosus dan S. aureus. Hasil kajian semasa 
menunjukkan bahawa daun C. nutans boleh bertindak sebagai sumber berpotensi ejen 
antimikrob dalam memerangi patogen oral. 
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CYTOTOXIC, MUTAGENIC AND ORAL PATHOGEN RELATED 
ANTIMICROBIAL PROPERTIES OF CLINACANTHUS NUTANS  
 
ABSTRACT 
 
Clinacanthus nutans (C. nutans) locally known as Sabah snake grass is a 
perennial herb that has been used traditionally in the treatment of various diseases in 
Malaysia. The objectives of this study were to determine the phytochemical 
compounds in the ethanol and aqueous extracts of C. nutans leaves using Gas 
Chromatography Mass Spectrometry (GCMS) and assessing their cytotoxic effect of 
using MTT assay on human gingival fibroblast cell line and then to evaluate their 
mutagenic effect using Ames test as well as to determine their antimicrobial properties 
using agar diffusion test and Minimal Inhibitory Concentration (MIC) assays. A total 
of 53 phytochemical compounds were identified from the extracts of C. nutans leaves. 
The compounds were classified into several classes: phenols, flavonoids, terpenoids, 
fatty acids, alkanes and hydrocarbons, esters, ketones, furans, sulfur and nitrogen 
compounds. In vitro cytotoxic study of ethanol and aqueous extracts of C. nutans 
leaves in various concentrations (6,400; 3,200; 1,600; 800; 400; 200; 100; 50 and 25 
µg/ml) on human gingival fibroblast cell line (HGF-1) using MTT assay did not exhibit 
any cytotoxic effect. Ames test on four types of S. Typhimurium strains, TA98, 
TA100, TA1535 and TA1537 treated with ethanol and aqueous extracts of C. nutans 
leaves did not show any mutagenic effect both in the presence and absence of 
metabolic activation system (S9) mix based on the number of revertant colonies. 
Antimicrobial study using agar well diffusion assay showed that the growth of 
Staphylococcus aureus (S. aureus) and Actinomyces viscosus (A. viscosus) were 
xxii 
 
inhibited by the ethanol and aqueous extracts of C. nutans leaves. However, the 
extracts did not exhibit any antimicrobial activity towards Enterococcus faecalis (E. 
faecalis), Porhyromonas gingivalis (P. gingivalis) and Candida albicans (C. albicans). 
Ethanol extract of C. nutans leaves showed better antimicrobial activity compared to 
the aqueous extract of C. nutans leaves against A. viscosus. Ethanol extract of C. 
nutans leaves showed MIC value of 102,400 µg/ml against A. viscosus and 204,800 
µg/ml against S. aureus. Aqueous extract of C. nutans leaves showed MIC values of 
204,800 µg/ml against A. viscosus and S. aureus. The results of the current study show 
that C. nutans leaves could act as a potential source of antimicrobial agent in 
combating oral pathogens.  
1 
 
CHAPTER 1 
INTRODUCTION 
 
1.1 Background of the study 
 
Clinacanthus nutans (Burm.f.) Lindau (C. nutans) known as Sabah snake grass in 
Malaysia belongs to Acanthaceae family. C. nutans is known as Sabah snake grass 
because this plant can be found mostly in Sabah. However, due to its beneficial value, 
C. nutans has been cultivated all around Malaysia (Sekar and Rashid, 2016). It has 
been used traditionally in Southeast Asia as a medicine to treat various ailments 
including lesions caused by Herpes simplex, diabetes mellitus and also as diuretics 
(Lau et al., 2014). C. nutans has been reported as an important traditional medicine 
that is widely used in China, Thailand and Malaysia that possesses various properties 
such as analgesic and anti-inflammatory activities (Satayavivad et al., 1996), antiviral 
activities against varicella-zoster virus (Thawaranantha et al., 1992) and Herpes 
simplex virus-2 (HSV-2) (Jayavasu et al., 1992). Research has shown that C. nutans 
also possesses antioxidant and anti-proliferative activity against cultured cell line, 
which suggests the potential of this plant to be a candidate for cancer therapy (Yong 
et al., 2013). 
 
A study revealed some bioactive compounds detected in C. nutans such as chlorophyll 
phaeophytin derivatives isolated from chloroform extract of C. nutans leaves and a 
mixture of cerebrosides and monoacylmonogalactosylglycerol isolated from the 
ethanol extracts of C. nutans leaves (Chelyn et al., 2014). These bioactive compounds 
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also have valuable pharmacological properties to prevent the Herpes simplex virus-1 
(HSV-1) activity (Chelyn et al., 2014).  
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1.2 Research problem 
 
According to World Health Organization (WHO) in 2013, oral health is important to 
human health and determination of human quality of life. Oral health can be defined 
as being free from mouth and facial pain, oral and throat cancer, oral infection and 
sores, periodontal (gum) disease, tooth decay, tooth loss, and other diseases and 
disorders that limit an individual’s capacity in biting, chewing, smiling, speaking, and 
psychosocial wellbeing. The most common oral diseases that affect humans worldwide 
are dental cavities, oral cancer, periodontitis, oral infectious disease, trauma due to 
injuries and hereditary lesions (WHO, 2013). 
 
Some of the preventions and treatments of oral diseases include lowering the sugar 
intake and maintaining a well-balanced nutritional intake to avoid tooth decay and 
premature tooth loss. Also, maintaining a constant low level of fluoride in the oral 
cavity also plays a major role in the prevention of dental cavities. Some of the clinically 
established sources of fluoride are antimicrobial mouth rinse and toothpaste. 
According to Shekar et al. in 2015, chlorhexidine gluconate is commonly used as 
mouth rinse. However, frequent use of chlorhexidine alters the taste sensation, staining 
of teeth and develops resistance of bacteria that incapacitate its application on long 
term basis (Shekar et al., 2015). Therefore, there is a need of finding alternative 
prevention and treatment options for oral diseases that are safe, effective and 
economical.  
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Discovery or development of new compounds from the medicinal plants with novel 
mode of action may also be a solution for other health complications which are 
antibiotic resistant bacteria outbreaks and diseases related to infection by bacteria 
(Nascimento et al., 2000; Dewanjee et al., 2007). Shekar and colleagues also suggested 
the use of medicinal plants for the control of oral or dental related diseases due to their 
lower negative impact and used to overcome an intrinsic (primary) resistance or 
secondary resistance to the drug during treatments.  Plant extracts, essential oils and 
purified phytochemicals can be used as potential agents to treat and prevent oral 
diseases (Palombo, 2011).  
 
C. nutans is one of the medicinal plants that has been proved to have antimicrobial 
properties towards bacteria. However, the complete potential of C. nutans has not been 
explored yet in the treatment and prevention of oral related diseases. The discovery of 
C. nutans as a treatment is highly important as bacterial infections are one of the major 
health problems all over the world (Adwan and Mhanna, 2008). The findings of new 
antimicrobial agents are very crucial since some of the bacterial strains are resistant 
against most of the clinical antibiotics (Adwan and Mhanna, 2008). In other words, C. 
nutans might be suitable for dental caries treatment and further studies must hence be 
conducted.  
 
1.3 Justification of the study 
 
Even though medicinal plants have been used traditionally by folklores to treat various 
diseases internally and externally, the possibility of these plants to become cytotoxic 
or mutagenic towards consumers should not be neglected. The fact that medicinal 
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plants contain advantageous bioactive compounds are known widely; however, the 
fact that these bioactive compounds might be poisonous and contain toxic compounds 
are not really exposed to the consumers. This study focuses on determining the 
possible phytochemical compounds present in C. nutans leaves and then to study its 
cytotoxicity, mutagenicity and antimicrobial properties. This will eventually enable in 
commercialization and prove its safety to be used in the treatment of dental caries or 
any oral related diseases. 
 
1.4 Objectives 
1.4.1 General objective 
 
The general objective of the study is to investigate the potential beneficial properties 
of Clinacanthus nutans for use in commercialization. 
 
1.4.2 Specific objectives 
 
1. To analyze the phytochemical compounds of Clinacanthus nutans using Gas 
Chromatography Mass Spectrometry. 
2. To determine the cytotoxic effect of Clinacanthus nutans using MTT assay on 
human gingival fibroblast cell line. 
3. To evaluate the mutagenic effect of Clinacanthus nutans using Ames test. 
4. To study the antimicrobial properties of Clinacanthus nutans using agar 
diffusion test and Minimal Inhibitory Concentration assays. 
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1.5 Research hypothesis 
 
Clinacanthus nutans leaves have non-cytotoxic, non-mutagenic and antimicrobial 
properties against oral pathogens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Clinacanthus nutans (Burm. f.) Lindau 
2.1.1 Botanical description  
 
Clinacanthus nutans (C. nutans) is a shrub that grows up to 1 to 3 meters in height. 
The leaf of this plant is simple, oppositely arranged, narrowly elliptic oblong or 
lanceolate and usually is 2.5-13 cm in length and 0.5-1.5 cm in width (Figure 2.1) (Ali 
et al., 2010). The leaf of C. nutans has a pointed or acuminates (tapering to a point) 
apex and the leaf margin is either exculpate-dentate or subentire. The leaf base of C. 
nutans is rounded, cuneate, obtuse and pubescent on the nerves and the petiole is 
around 3-15 mm in length (Ali et al., 2010). The leaf blade is lanceolate-ovate, 
lanceolate or linear-lanceolate, while, the surface is pubescent when young then 
glabrescent. This plant has pubescent branches with cylindrical, striate and glabrescent 
stems (Perry and Metzger, 1980). The stem of C. nutans is small, soft, thin and slightly 
curved that looks like the curve of an elephant’s trunk (Shim et al., 2013). Therefore, 
in Malay C. nutans was known as Belalai gajah (elephant’s trunk). Generally, C. 
nutans plant reproduces using vegetative propagation by stem cuttings (Panyakom, 
2006; Ali et al., 2010). The synonyms of C. nutans are Justicia nutans, C. agustus, C. 
burmanni, C. spirei and C. siamensis (Hu et al., 2011; Ng, 2013). Common vernacular 
names for C. nutans are listed in Table 2.2. Taxonomically, C. nutans is classified by 
kingdom, phylum, class, order, family, genus and species (Table 2.1) as per Hassler, 
(2000). 
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Figure 2.1: a: whole plant; b: leaves with stem of Clinacanthus nutans 
 
 
 
 
 
a b  
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Table 2.1: Taxonomy of C. nutans 
Kingdom: Plantae 
Phylum: Tracheophyta  
Class: Magnoliopsida  
Order: Lamiales  
Family: Acanthaceae 
Genus: Clinacanthus 
Species: Clinacanthus nutans (Burm. f.) Lindau 
        
Table 2.2: Vernacular names of C. nutans 
Vernacular name Country/Language References 
Belalai gajah Peninsular Malaysia, Brunei Alam et al., (2016) 
Sabah snake grass East Malaysia, Brunei Alam et al., (2016) 
Dandang gendis, Ki tajam Indonesia Ng, (2013) 
Sha Be She Cao, Qing jian China Teshima et al., (1998) 
Phaya yo, Phak man kai Thailand 
Teshima et al., (1998); 
Ali et al., (2010) 
 
2.1.2 Origin and distribution 
 
C. nutans is native throughout Southeast Asia, particularly in Thailand, Malaysia and 
China (Tuntiwachwuttikul et al., 2004). C. nutans is also commonly found in tropical 
Asian regions such as Vietnam, Indonesia, Brunei and some temperate regions (Le et 
al., 2017). C. nutans belongs to Acanthacea family, which is a large flowering plant 
family that comprises around 220 genera and 4000 species (Hu et al., 2011). Most of 
the species are pantropical and subtropical family and mainly distributed in Indonesia, 
Malaysia, Africa, Madagascar, Brazil and Central America with a few of them 
distributed in Mediterranean, Australia, United States and China (Meyer and 
Lavergne, 2004; Alam et al., 2016). 
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2.1.3 Phytochemical compounds in Clinacanthus nutans 
 
Phytochemicals are bioactive chemical compounds that are present naturally in 
medicinal plants (Wadood et al., 2013) and possess defence mechanisms or disease 
preventive properties (Afolabi and Afolabi, 2013). Phytochemicals are composed of 
two categories which are primary and secondary constituents (Wadood et al., 2013) 
based on their function in the plant metabolism (Afolabi and Afolabi, 2013). Primary 
constituents contain amino acids including chlorophyll, proteins and sugar (Wadood 
et al., 2013).  Meanwhile, secondary constituents consist of terpenoids, flavonoids, 
phenolics, saponins and alkaloids (Afolabi and Afolabi, 2013). Compounds produced 
by plants having pharmacological or toxicological effects in humans and animals when 
ingested are known as bioactive compounds (Bernhoft et al., 2010). Basically, 
bioactive compounds such as n-hexadecanoic acid, 1, 2-benzenedicarboxylic acid, 
diisooctyl ester and tetradecanoic acid present in the plants are produced as secondary 
constituents. 
 
As part of medicinal plants, C. nutans also possesses a wide range of phytochemicals 
such as terpenoids, flavonoids, glycosides, steroids, phenolic compounds, saponins 
and tannins. Previous study on preliminary screening of phytochemical compounds 
reported the presence of secondary constituents in methanol extract of C. nutans leaves 
including saponins, phenolic compounds, flavonoids, diterpenes and phytosterols (Ho 
et al., 2013). Recent study reported the presence of flavonoid compounds such as 
catechin, quercetin, kaempferol and luteolin in methanol extract of C. nutans leaves 
and buds (Ghasemzadeh et al., 2014). 
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An earlier study by Dampawan et al. (1977) reported the isolation of compounds 
known as stigmasterol, lupeol and β-sitosterol from light petroleum extract of C. 
nutans stems (Dampawan et al., 1977). In 1997, Teshima and colleagues successfully 
isolated six known C-glycosyl flavones; vitexin, isovitexin, shaftoside, isomollupentin 
7-O-β-glucopyranoside, orientin and isoorientin from the butanol and water-soluble 
portion of the methanol extract of C. nutans stems and leaves (Teshima et al., 1997). 
In a further study on C. nutans extract, Teshima et al. (1998) isolated and identified 
five new sulfur-containing glucoside compounds known as clinacoside A, clinacoside 
B, clinacoside C, cycloclinacoside A1 and cycloclinacoside A2 using column 
chromatography (Teshima et al., 1998).  
 
Study on leaf extract of C. nutans resulted in identification of two glycoglycerolipids; 
1,2-Odilinolenoyl-3-O-β-D-galactopyranosyl-glycerol and 1-O-palmitoyl-2-
Olinolenoyl-3-O-[α-D-galactopyranosyl-(1"→6')-O-β-D-galacctopyranosyl] glycerol 
(Satakhun, 2001). Another study on separation of compounds of chloroform extract of 
C. nutans leaves resulted in identification of three new compounds related to 
chlorophyll a and b which were 132-hydroxy-(132-S)-phaeophytin b (chlorophyll b), 
purpurin 18 phytyl ester and phaeophorbide a (chlorophyll a) (Dechatiwongse na 
Ayudhya et al., 2001). Previous study has reported the isolation of a mixture of nine 
cerebrosides and a monoacylmonogalactosylglycerol from ethyl acetate (EtOAc) 
soluble fraction of ethanol extract of C. nutans (Tuntiwachwuttikul et al., 2004).  
 
Sakradat and team discovered five new compounds related to chlorophyll a and b; (i) 
132-hydroxy-(132-S)-chlorophyll b, (ii) 132-hydroxy-(132-R)-chlorophyll b, (iii) 132-
hydroxy-(132-R)-phaeophytin b, (iv) 132-hydroxy-(132-S)-phaeophytin a and (v) 132-
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hydroxy-(132-R)-phaeophytin a from C. nutans extract (Sakdarat et al., 2006). Recent 
study on ethanol extract of C. nutans aerial parts identified four new sulphur-
containing compounds which are clinamide A, clinamide B, clinamide C and 2-cis-
entadamide A (Tu et al., 2014). Huang and team identified flavonol glycoside 
compounds which were shaftoside, orientin, vitexin, isoorientin, isovitexin and 6,8-
apigenin-C-α-L-pyranarabinoside in ethanol extract of C. nutans aerial parts (Huang 
et al., 2016). They also reported that the ethanol extract of C. nutans aerial parts 
possessed antitumor and immunomodulatory. Recently, some studies and 
investigations on C. nutans extract have identified some phytochemical compounds as 
listed in Table 2.3. Lupeol has been identified by most of the researchers in their study.  
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Table 2.3: Phytochemical compounds present in C. nutans plants 
Compound Class Reference 
alpha-tocopherol Terpenoids Alam et al., (2017) 
beta-amyrin Triterpenoids Teoh et al., (2017) 
beta-sitosterol Phytosterols Teoh et al., (2017) 
beta-tocopherol Terpenoids Alam et al., (2017) 
Betulin Triterpenoids Teoh et al., (2017) 
Campesterol Phytosterols Teoh et al., (2017) 
Dimethyl trisulfide Organosulfur Mustapa et al., (2015) 
gamma-sitosterol Phytosterols Teoh et al., (2017) 
gamma-tocopherol Terpenoids Alam et al., (2017) 
Hexadecanoic acid/palmitic acid Fatty acid Alam et al., (2017) 
Isoorientin Flavones Mustapa et al., (2015) 
Isoschaftoside C-Glycosylated flavone Mustapa et al., (2015) 
Kaempferol Flavones Mustapa et al., (2015) 
Kaempferol-7-neohesperidoside Flavones Mustapa et al., (2015) 
Linoleic acid, ethyl ester Fatty acid Mustapa et al., (2015) 
Linoleic acid, methyl ester Fatty acid Mustapa et al., (2015) 
Lup-20(29)-en-3-one Triterpenoids Teoh et al., (2017) 
Lupeol Triterpenoids Teoh et al., (2017) 
Myristic acid Fatty acid Alam et al., (2017) 
Neophytadiene Diterpene Mustapa et al., (2015) 
Oleic acid Fatty acid Teoh et al., (2017) 
Palmitic acid, methyl ester Fatty acid Mustapa et al., (2015) 
Phenol,2,6-dimethoxy Phenol Mustapa et al., (2015) 
Phytol Diterpene Mustapa et al., (2015) 
Quercetin Flavonoids Alam et al., (2017) 
Squalene Triterpenoids 
Teoh et al., (2017); 
Mustapa et al., (2015) 
Stearic acid Fatty acid 
Alam et al., (2017); 
Mustapa et al., (2015) 
Stearic acid, methyl ester Fatty acid Mustapa et al., (2015) 
Stigmasterol Phytosterols Teoh et al., (2017) 
Vitamin E Terpenoids Teoh et al., (2017) 
Vitexin C-Glycosylated flavone Mustapa et al., (2015) 
2-cyclopenten-1-one, 2-hydroxy Cyclic ketone Mustapa et al., (2015) 
4H-Pyran-4-one,2,3-dihydro-3,5-
dihydroxy-6-methyl 
Flavonoid fraction 
Mustapa et al., (2015) 
4-vinyl-2-methoxy-phenol Phenol Mustapa et al., (2015) 
4-vinylphenol Phenol Mustapa et al., (2015) 
7,9-Dodecadien-1-ol Alcohol Mustapa et al., (2015) 
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2.1.4 Medicinal uses of Clinacanthus nutans 
 
In Thailand, fresh leaves of C. nutans have been used traditionally to treat ailments 
like skin rashes, pruritic rashes, insect and snake bites as well as lesions caused by 
Herpes simplex virus (HSV) and Varicella-zoster virus (VZV) (Sakdarat et al., 2006; 
Chotchoungchatchai et al., 2012). The fresh leaves of C. nutans are used as anti-snake 
venom among traditional practitioners in Thailand (Sakdarat et al., 2009).  Apart from 
that, C. nutans has been used as lotion or cream for the treatment of genital Herpes and 
Varicella-zoster lesions as well as to relieve skin inflammation and insect bites 
(Sakdarat et al., 2009). Chotchoungchatchai et al. (2012) suggested that the use of 
ethanol extract of C. nutans dissolved in glycerine solution to treat aphthous ulcer and 
Herpes simplex and the extraction of C. nutans plant with palm oil to treat burns 
(Chotchoungchatchai et al., 2012). In Indonesia, decoction of fresh leaves of C. nutans 
is used to treat dysentery and diabetes (Roeslan et al., 2012; Arullappan et al., 2014).  
 
In China, the whole plant of C. nutans is used to treat inflammatory conditions such as 
haematoma, contusion, strains and sprains of injuries and rheumatism (Ghasemzadeh 
et al., 2014). In Malaysia and Singapore, most of the traditional practitioners prefer to 
consume the decoction of fresh leaves of C. nutans with water as herbal tea to boost 
immunity and in the treatment for benign growth on pituitary glands (Siew et al., 
2014). In instances, raw stems and leaves of C. nutans are eaten for detoxification 
purposes and for benign growth on thyroid glands. Apart from that, the stems of C. 
nutans are consumed as juice and tea for health promotion, breast cancer treatment, 
bowel movement promotion, cold and flu treatment as well as bath to promote 
healthier skin (Siew et al., 2014). 
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2.2 Reported pharmacological studies of Clinacanthus nutans 
 
C. nutans possesses variety of pharmacological properties including antimicrobial, 
anti-venom, anti-inflammatory, anti-rheumatism, antiviral and antioxidant properties.  
 
2.2.1 Antimicrobial properties 
 
Chomnawang and colleagues reported the antimicrobial activity of C. nutans on 
bacteria triggering inflammation in acne, namely, Propionibacterium acnes (P. acnes) 
and Staphylococcus epidermidis (S. epidermidis) (Chomnawang et al., 2005). Ho and 
colleagues also reported that the methanol extract of C. nutans possessed antibacterial 
effect against skin pathogens, P. acnes and S. epidermidis as well as Staphylococcus 
aureus (S. aureus), Bacillus cereus (B. cereus) and Escherichia coli (E. coli) (Ho et 
al., 2013). Study on the antibacterial activities of medicinal plants against S. aureus, 
Micrococcus luteus (M. luteus), E. coli and Pseudomonas aeruginosa (P. aeruginosa) 
showed that C. nutans extract exhibited antibacterial activity against these bacteria 
(Wong et al., 2013). 
 
Ethyl acetate crude extract of C. nutans leaves and its seven fractions (F1, F2, F3, F4, 
F5, F6 and F7) exhibited antimicrobial activity against B. cereus, Candida albicans 
(C. albicans), E. coli and Salmonella enterica Typhimurium with F7 showed the 
strongest antimicrobial activity (Arullappan et al., 2014). Recent study on the 
antimicrobial activity of aqueous and methanol extracts of C. nutans against three 
aquatic pathogenic bacteria, Streptococcus agalactiae (S. agalactiae), Aeromonas 
hydrophila (A. hydrophila) and Enterobacter cloacae (E. cloacae) showed that the 
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aqueous extract of C. nutans exhibited moderate antimicrobial activity against S. 
agalactiae and E. cloacae, while, methanol extract inhibited the growth of A. 
hydrophila (Raina and Hassan, 2016; Sekar and Rashid, 2016). 
 
2.2.2 Anti-inflammatory properties 
 
Traditionally, C. nutans has been used as an anti-inflammatory agent in the treatment 
of insect bites and allergic responses, although there is a limited study on the 
investigation of anti-inflammatory activity of C. nutans. A study by Wanikiat et al. 
proposed the anti-inflammatory properties of C. nutans extract on human neutrophils 
using two neutrophil-dependent acute inflammatory models (Wanikiat et al., 2008). 
The results suggested that there was significant inhibition of myeloperoxidase (MPO) 
activity in the inflamed tissue showing that the anti-inflammatory effect of the C. 
nutans extracts was related to reduced neutrophil migration (Wanikiat et al., 2008).  
 
2.2.3 Antiviral properties 
 
Kunsorn et al. suggested C. nutans to be an anti-HSV agent and their results revealed 
that n-hexane, dichloromethane and methanol extracts of C. nutans can inhibit the 
plaque formation of HSV-1 and HSV-2. Phytochemical compounds from C. nutans 
leaves such as polyphenolic, glycosides and terpenes were found to possess antiviral 
properties against HSV (Kunsorn et al., 2013). Sakdarat et al. (2009) discovered the 
inhibitory activities of C. nutans as an antiviral agent against HSV-1F in pre-viral entry 
step (Sakdarat et al., 2009).  The meta-analysis study by Kongkaew and 
Chaiyakunapruk (2011) reported that C. nutans extract possessed potential beneficial 
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antiviral properties in the treatment of Herpes genitalis and Herpes zoster (Kongkaew 
and Chaiyakunapruk, 2011). 
 
2.2.4 Antioxidant properties 
 
Investigation of C. nutans extracts (chloroform, methanol and water) on diphenyl-1-
picrylhydrazyl (DPPH), galvinoxyl radical, nitric oxide, and hydrogen peroxide 
scavenging assays revealed that C. nutans extracts contained antioxidant agents that 
were capable of negating free radicals (Yong et al., 2013). However, the antioxidant 
activities of the extract varied for each test due to the solubility of the extracts in 
different testing systems and the stereo selectivity of the radicals (Yong et al., 2013 ). 
A study by Yuann et al. inspected the antioxidant activity of C. nutans extracts on 
plasmid DNA integrity in E. coli (Yuann et al., 2012). The antioxidant activities, 
DPPH radical scavenging activity, reducing power activity, SOD activity, and total 
phenolic contents of C. nutans were lowered when compared with green tea. However, 
C. nutans leaf extract showed better retention of the integrity of super-coiled plasmid 
DNA under riboflavin photochemical treatment compared to extracts of green tea 
(Yuann et al., 2012). 
 
2.2.5 Cytotoxic properties 
 
Chloroform and water extracts of C. nutans leaf extracts did not exhibit cytotoxic 
effect on human umbilical veins endothelial cells (HUVECs) and only showed 
significantly lower per cent of inhibition with IC50 below 20 µg/ml compared to other 
cancer cells (Yong et al., 2013). In vitro cytotoxicity study on petroleum ether, ethyl 
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acetate and methanol extracts of C. nutans leaves using MTT assay after incubation 
for 72 hours revealed that petroleum ether extract showed strongest inhibition on 
human cervical cancer cell line, Henrietta Lacks (HeLa) and human erythroleukemia 
cell line (K-562) with IC50 values with 18 and 20 µg/ml, respectively (Arullappan et 
al., 2014). Recent study by Teoh et al. (2017) demonstrated that the methanol and ethyl 
acetate extracts of C. nutans roots promoted apoptosis on human breast cancer cell 
line, Michigan cancer foundation-7 (MCF-7) and HeLa but only showed no or little 
inhibition towards cells mouse embryonic fibroblast cell line, National Institutes of 
Health, 3-day transfer, inoculum 3×105 (NIH 3T3) (Teoh et al., 2017). Several 
researchers claimed IC50 value for in vitro screening of cytotoxicity activity of crude 
extract, which was less than 20 µg/ml for incubation between 48-72 hours (Yong et 
al., 2013; Kuete and Efferth, 2014; Graidist et al., 2015).  
 
2.3 Determination of phytochemical compounds by chromatography analysis 
 
According to International Union of Pure and Applied Chemistry (IUPAC), the term 
chromatography can be defined as physical method of separation between two phases 
of compounds which are stationary phase and mobile phase (moves in a definite 
direction). Chromatography analysis has been used widely in the separation and 
analyses of complex mixtures or compounds (Christian, 2004). Basically, 
chromatography analysis can be divided into two principles of analysis including gas 
chromatography (GC) and liquid chromatography (LC) (Christian, 2004). 
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Theoretically, chromatography analysis is based on the solubility of the components 
in a mixture to the stationary and mobile phases. The components in a mixture will be 
separated according to their mobility differences (Sliepcevich and Gelosa, 2009). 
 
2.3.1 Gas chromatography separation 
 
Main components required in GC separations include (i) column (packed with 
stationary phase), (ii) heater (to heat the column), (iii) gas flow (inert carrier gas) and 
(iv) detection device (detection of compounds either by flame ionization or electron 
capture) (Harborne, 1973).  According to Christian, the test sample injected to the 
heated port is converted to the vapour state. Then, the results are presented in terms of 
retention volume, Rv, or retention time, Rt (Christian, 2004). Rv can be defined as 
volume of carrier gas needed for elution of components from the column, while, for 
Rt specific time required for sample to be eluted (Harborne, 1973).  
 
The chromatographic peaks are identified by measuring the peaks at each Rt area and 
compare their height with standard of pure substance. Detection system device can 
read the readout of the peak area automatically together with the Rt.  However, the 
identification of the peaks in more complex mixtures or samples are not easy to be 
identified, thus, a more sensitive and selective detector can be used which is mass 
spectrometry (MS) instrument. MS is known based on the detection of mass of the 
compound (formula weight and fragmentation pattern) (Christian, 2004).  
Combination of GC and MS technique is known as gas chromatography mass 
spectrometry (GCMS) (Christian, 2004).  
 
20 
 
Phytochemical compounds analysis of the plant extracts is very important 
commercially to produce new drugs by identifying specific compounds that possess 
pharmacological properties to cure various diseases (Wadood et al., 2013). Several 
techniques are used by several researchers to determine the phytochemical compounds 
present in plant extracts and one of the techniques is GCMS. 
 
2.3.1(a) Gas chromatography mass spectrometry analysis 
 
GCMS technique is the combination of gas chromatography technique with mass 
spectrometry technique and established mainly for the study of volatile, active and 
stable compounds. Scientifically, GC is used widely for the determination of organic 
compounds whereas, MS is a very sensitive and selective detector to identify various 
components based on their mass spectra. The universal detection technique, high 
selectivity and very high sensitivity have made GCMS suitable for qualitative and 
quantitative analyses for volatile and semi-volatile compounds (Hubschmann, 2008; 
Kumar et al., 2011). 
 
2.3.2 Liquid chromatography separations 
 
LC separation requires a sample or mixture to be dissolved in solvent before separating 
the ions or components (Sliepcevich and Gelosa, 2009). Conventional LC used large 
column and large particles resulted in slow diffusion rates compared to GC (Christian, 
2004). High performance liquid chromatography (HPLC) has been developed to 
improve the classical LC and to minimize diffusion as well as the time required for the 
movement of sample components (Christian, 2004).   
21 
 
2.3.2(a) High performance liquid chromatography analysis 
 
HPLC is a technique for the separation and determination of organic and inorganic 
compounds in test samples from biologicals, pharmaceuticals, foods, industrials and 
environment (Ingle et al., 2017). HPLC analysis uses a specific pump to force the 
mobile phase through, thus, giving higher resolution in a short time of analysis 
(Sliepcevich and Gelosa, 2009). Usually, HPLC analysis is used to detect non-volatile 
compounds such as lipids, sugars, higher terpenoids and alkaloids (Harborne, 1973).  
 
GCMS and HPLC have been used widely to analyse phytochemical compounds in 
plant extracts qualitatively and quantitatively (Proestos et al., 2006). However, 
comparing HPLC with GCMS, HPLC has limitation in analysing and identifying the 
compounds, thus, GCMS analysis can provide more accurate results with better 
analysis (Proestos et al., 2006). In this study, the phytochemical compounds of the 
extracts of C. nutans leaves were determined by GCMS analysis. 
.  
2.4 Cytotoxicity  
 
Cytotoxicity is a broad term and has ambiguous meaning (Niles et al., 2008). 
Cytotoxicity is defined as quality of being toxic to cells; either the cells are killed or 
have their metabolism being altered (Freshney, 2010). The term cytotoxicity can also 
be described as the cascade of molecular events that interrupt with macromolecular 
synthesis, resulting in unequivocal cellular, functional, and structural damage 
(Aldridge, 1993). In other words, cytotoxicity indicates which test substances have 
specific destructive action on certain cells (Freshney, 2010). Therefore, cytotoxicity 
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assays are widely performed to identify the test substances or compounds, including 
plant-derived extracts and purified compounds that are intended for use as 
pharmaceutical or cosmetic products are non-toxic (McGaw et al., 2014).  
 
Plant extracts contain various compounds that attribute to biological activities and 
properties. Based on Paracelsus’ recognition, all compounds including compounds 
from plant extracts, have the capacity to be poisonous depending on the dosage or 
concentration. Cytotoxicity study is considered as a first step used in evaluating and 
screening the toxicity of test substances including biological activity of plant extracts 
and active compounds isolated from plants (McGaw et al., 2014). Niles and team 
suggested that cytotoxicity testing is important to identify and define safety thresholds 
for all new potential chemotherapeutics (Niles et al., 2009). Besides, cytotoxicity 
testing also allows researchers to evaluate new antimicrobial or other bioactivities of 
plant extracts or compounds since these compounds or plant extracts are identified as 
non-toxic (McGaw et al., 2014).  
 
In vitro cytotoxicity tests on cell line serve as useful method to define basal 
cytotoxicity such as intrinsic ability of a certain test substances to cause cell death. In 
conjunction with in vitro cell culture systems, test substances are considered being 
cytotoxic if the test substances interfere with the cell attachments, significantly alters 
cell morphology, affects the rate of cell growth and causes the cells to die (Horvath, 
1980). Apart from that, cytotoxicity is also very important in determining the 
concentration range for further and more detailed in vitro testing by providing useful 
and meaningful information on parameters such as genotoxicity, induction of 
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mutations or programmed cell death. Cytotoxicity data also can be applied as a 
predictor of acute systemic toxicity (Eisenbrand et al., 2002).  
 
There are different types of cytotoxicity assays used to evaluate cell viability and the 
choice of suitable viability assay to use for cytotoxicity test depends on the nature of 
the test substance, the expected response, and the target cell (Freshney, 2010; McGaw 
et al., 2014). Common cytotoxicity or cell viability assays are identified based on 
metabolic activity measurements for detection of cytotoxic effects of plant extracts and 
purified plant compounds (Bunel et al., 2014; McGaw et al., 2014). Metabolism 
reductase viability assays can be classified into two classes; tetrazolium and resazurin 
assays (Bunel et al., 2014; McGaw et al., 2014).   
 
2.4.1 Tetrazolium-based assays 
 
Tetrazolium assay is the most widely used assay to screen the viability of cells. 
Tetrazolium assays are known as quantitative colorimetric assays for mammalian cell 
survival and these assays detect living cells and not the dead cells (Mosmann, 1983). 
Tetrazolium assays can be differentiated by the different salts used in the assays. 
Common salts used in the tetrazolium assays include MTT, XTT, MTS and WST-1 
(Bunel et al., 2014; McGaw et al., 2014). Tetrazolium salts act as redox sensors that 
can be reduced into coloured formazan products by metabolically active cells (Bunel 
et al., 2014). According to Riss et al. (2013), MTT salt is positively charged, while, 
XTT, MTS and WST-1 salts are negatively charged (Riss et al., 2013).  
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2.4.1(a) MTT assay 
 
In this study, MTT assay was applied to determine the cytotoxicity effect of C. nutans. 
According to Akhir et al. (2011), MTT assay is a rapid and high accuracy colorimetric 
assay that has been used widely to determine cell growth and cell cytotoxicity (Akhir 
et al., 2011). The first tetrazolium salt, MTT or 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay introduced by Mosmann in 1983 is a technique that 
determines the cell survival using different end points (Mosmann, 1983). MTT assay 
is a quantitative and reliable colorimetric assay that measures viability, proliferation 
and activation of cells in a multi-well.  
 
The principle of this assay is based on the reduction of yellow water soluble 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) (Figure 2.2) by 
metabolically active viable cells (via mitochondrial and cytosolic enzymes) to a blue-
purple formazan derivative after treating with test chemicals or substances (Mosmann, 
1983; McGaw et al., 2014). The mitochondrial dehydrogenase at the cytochrome b and 
cytochrome c sites of living cells alter the formazan salt from soluble to an insoluble, 
purple formazan derivative (Li et al., 2015). The insoluble formazan derivative 
accumulates within cells as it cannot pass through cell membranes (McGaw et al., 
2014). Dimethyl sulfoxide (DMSO) is used to solubilize the insoluble formazan 
derivative and then, the coloured product can be measured quantitatively by 
spectrophotometer where the results are directly proportional to the number of viable 
cells (Bean et al., 1995; Ruben and Neubauer, 1987; Riss et al., 2013). The formation 
of purple coloured product shows the presence of viable cells since when the cells die, 
they lose the ability to convert MTT into formazan. Based on McGaw et al. (2014), 
